Drug utilisation on a preterm and neonatal intensive care unit in Germany: A prospective, cohort-based analysis

European Journal of Clinical Pharmacology

Volumn 66, Issue 1, 2010, Pages 87-95

  Neubert, Antje ^a   Lukas, Kristin ^b   Leis, Thomas ^b   Dormann, Harald ^b   Brune, Kay ^b   Rascher, Wolfgang ^b  

^a UNIVERSITY OF LONDON   (United Kingdom)

^b UNIVERSITY OF ERLANGEN NUREMBERG   (Germany)

Author keywords

Drug utilisation; Neonatal intensive care unit; Neonates; Off label; Preterm; Unlicensed

Indexed keywords

ANALGESIC AGENT; ANTIBIOTIC AGENT; CENTRAL NERVOUS SYSTEM AGENTS; RESPIRATORY TRACT AGENT;

ARTICLE; COHORT ANALYSIS; DRUG USE; DRUG UTILIZATION; FEMALE; GERMANY; GESTATIONAL AGE; HOSPITALIZATION; HUMAN; INFANT; LICENSING; MAJOR CLINICAL STUDY; MALE; NEWBORN; NEWBORN INTENSIVE CARE; PREMATURITY; PRESCRIPTION; PRIORITY JOURNAL; PROSPECTIVE STUDY; UNIVERSITY HOSPITAL;

DRUG APPROVAL; DRUG LABELING; DRUG UTILIZATION; FEMALE; GERMANY; HOSPITALIZATION; HOSPITALS, PEDIATRIC; HUMANS; INFANT, NEWBORN; INFANT, PREMATURE; INTENSIVE CARE UNITS, NEONATAL; LENGTH OF STAY; MALE; OFF-LABEL USE; PROSPECTIVE STUDIES;

EID: 76949105222     PISSN: 00316970     EISSN: None     Source Type: Journal    
DOI: 10.1007/s00228-009-0722-8     Document Type: Article

References (29)

1. W Du I Warrier V Tutag Lehr V Salari E Ostrea JV Aranda 2006 Changing patterns of drug utilization in a neonatal intensive care population Am J Perinatol 23 279 285 10.1055/s-2006-946719 16799916
2. S Saigal LW Doyle 2008 An overview of mortality and sequelae of preterm birth from infancy to adulthood Lancet 371 261 269 10.1016/S0140-6736(08)60136-1 18207020
3. U Lindner A Hilgendorff G Frey L Gortner 2008 Drug utilisation in very preterm infants: any changes during the past decade? Klin Padiatr 220 238 242 10.1055/s-2008-1046786 1:STN:280:DC%2BD1cvntlSrsA%3D%3D 18401813
4. I Warrier W Du G Natarajan V Salari J Aranda 2006 Patterns of drug utilization in a neonatal intensive care unit J Clin Pharmacol 46 449 455 10.1177/0091270005285456 16554453
5. European Commission (2006) Regulation (EC) No. 1901/2006 of the European Parliament and of the Council on medicinal products for paediatric use. European Commission, Brussels
6. A Neubert C Planner N Cranswick 2008 The new European regulation on pediatric medicines: safety and ethics perspectives Paediatr Drugs 10 147 149 10.2165/00148581-200810030-00003 18454567 (Pubitemid 351629670)
7. Senate and House of Representatives of the United States of America (2003) Pediatric Research Equity Act of 2003
8. World Health Organisation (2007) Making medicines child size. World Health Organisation, Geneva
9. M Dell'Aera AR Gasbarro M Padovano N Laforgia D Capodiferro B Solarino R Quaranta AS Dell'Erba 2007 Unlicensed and off-label use of medicines at a neonatology clinic in Italy Pharm World Sci 29 361 367 10.1007/s11096-006-9081-z 17351821 (Pubitemid 47196657)
10. S Turner AJ Nunn K Fielding I Choonara 1999 Adverse drug reactions to unlicensed and off-label drugs on paediatric wards: a prospective study Acta Paediatr 88 965 968 10.1080/08035259950168469 1:STN:280:DyaK1Mvks1yhtQ%3D%3D 10519338 (Pubitemid 29448261)
11. WHO Collaborating Centre for Drug Statistics Methodology. Anatomical-Therapeutical-Chemical (ATC) Classification-Index and Guidelines. World Health Organisation, Geneva
12. AJ Daniell BA Darlow 1989 Audit of drug usage in a regional neonatal intensive care unit Aust Paediatr J 25 207 210 1:STN:280:DyaK3c%2FntlCrtQ%3D%3D 2590115
13. SM Lesko MF Epstein AA Mitchell 1990 Recent patterns of drug use in newborn intensive care J Pediatr 116 985 990 10.1016/S0022-3476(05)80665-1 1:STN:280:DyaK3c3ntFSgsQ%3D%3D 2112190 (Pubitemid 20201715)
14. L Gortner U Bernsau M Brand HH Hellwege G Hieronimi G Jorch HL Reiter H Versmold 1991 Drug utilization in very premature infants in neonatal intensive care units Dev Pharmacol Ther 17 167 171 1:STN:280:DyaK3s%2FkvVCqsw%3D%3D 1841833
15. S Conroy J McIntyre I Choonara 1999 Unlicensed and off label drug use in neonates Arch Dis Child Fetal Neonatal Ed 80 F142 F144 10.1136/fn.80.2.F142 1:STN:280:DyaK1M3lslKntg%3D%3D 10325794
16. Turner MA, Lewis S, Field D (2008) Priorities in neonatal medicines research: a scoping exercise, Abstract, Biannual Meeting ESDPP, Rotterdam
17. CP O'Donnell RJ Stone CJ Morley 2002 Unlicensed and off-label drug use in an Australian neonatal intensive care unit Pediatrics 110 e52 10.1542/peds.110.5.e52 12415058
18. RH Clark BT Bloom AR Spitzer DR Gerstmann 2006 Reported medication use in the neonatal intensive care unit: data from a large national data set Pediatrics 117 1979 1987 10.1542/peds.2005-1707 16740839 (Pubitemid 46071242)
19. Gordon A, Jeffery HE (2005) Antibiotic regimens for suspected late onset sepsis in newborn infants. Cochrane Database Syst Rev CD004501
20. GS Cunha FF Mezzacappa JD Ribeiro 2003 Maternal and neonatal factors affecting the incidence of bronchopulmonary dysplasia in very low birth weight newborns J Pediatr (Rio J) 79 550 556
21. DG Sweet HL Halliday 2000 A risk-benefit assessment of drugs used for neonatal chronic lung disease Drug Saf 22 389 404 10.2165/00002018-200022050- 00006 1:CAS:528:DC%2BD3cXktVGktb4%3D 10830255
22. Stevens TP, Blennow M, Myers EH, Soll R (2007) Early surfactant administration with brief ventilation vs. selective surfactant and continued mechanical ventilation for preterm infants with or at risk for respiratory distress syndrome. Cochrane Database Syst Rev CD003063
23. Soll RF, Morley CJ (2001) Prophylactic versus selective use of surfactant in preventing morbidity and mortality in preterm infants. Cochrane Database Syst Rev CD000510
24. Yost CC, Soll RF (2000) Early versus delayed selective surfactant treatment for neonatal respiratory distress syndrome. Cochrane Database Syst Rev CD001456
25. JV Been LJ Zimmermann 2007 What's new in surfactant? A clinical view on recent developments in neonatology and paediatrics Eur J Pediatr 166 889 899 10.1007/s00431-007-0501-4 1:CAS:528:DC%2BD2sXotVOmt7c%3D 17516084 (Pubitemid 47101354)
26. JL Hughes E McCall F Alderdice J Jenkins 2006 More and earlier surfactant for preterm infants Arch Dis Child Fetal Neonatal Ed 91 F125 F126 10.1136/adc.2005.073148 1:STN:280:DC%2BD287gsFCltQ%3D%3D 16492949 (Pubitemid 43325532)
27. S Avenel A Bomkratz G Dassieu JC Janaud C Danan 2000 The incidence of prescriptions without marketing product license in a neonatal intensive care unit Arch Pediatr 7 143 147 10.1016/S0929-693X(00)88083-5 1:STN:280: DC%2BD3c7msFyrtw%3D%3D 10701058
28. C Knoeppel O Klinger M Soergel HW Seyberth A Leonhardt 2000 Anwendung von Medikamenten auerhalb der Zulassung oder ohne Zulassung bei Kindern Monatsschr Kinderheilkd 148 904 908 10.1007/s001120050670 (Pubitemid 30822067)
29. European Medicine Agency (2008) Priority list of off-patent medicinal products for paediatric studies. EMEA, London